Seronegative Neuromyelitis Optica Spectrum--the challenges on disease definition and pathogenesis

Arq Neuropsiquiatr. 2014 Jun;72(6):445-50. doi: 10.1590/0004-282x20140032.

Abstract

Neuromyelitis optica spectrum disorders (NMOSD) are characterized by severe optic neuritis and/or longitudinally extensive transverse myelitis, and some brain lesions are also unique to NMOSD. Serum autoantibodies against aquaporin-4 (AQP4) are detected in most cases of NMOSD. However, some patients with NMOSD remain seronegative despite repetitive testing during attacks with highly sensitive cell-based assays. The differential diagnosis of NMOSD is not restricted to multiple sclerosis and it includes many diseases that can produce longitudinally extensive myelitis and/or optic neuritis. We review the clinical features, imaging, and laboratory findings that can be helpful on the diagnostic work-up, discuss the differences between AQP4 antibody positive and negative patients with NMOSD, including features of NMOSD with antibodies against myelin oligodendrocyte glycoprotein.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Aquaporin 4 / immunology
  • Autoantibodies / immunology
  • Diagnosis, Differential
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Myelin-Oligodendrocyte Glycoprotein / immunology
  • Neuromyelitis Optica / diagnosis*
  • Neuromyelitis Optica / immunology*
  • Spinal Cord Injuries / diagnosis
  • Spinal Cord Injuries / immunology

Substances

  • Aquaporin 4
  • Autoantibodies
  • Myelin-Oligodendrocyte Glycoprotein